Connection

Search Results to

This is a "connection" page, showing the details of why an item matched the keywords from your search.


One or more keywords matched the following properties of Small molecule inhibitors of Late SV40 Factor (LSF) abrogate hepatocellular carcinoma (HCC): Evaluation using an endogenous HCC model.

PropertyValue
has minor subject area list Animals; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Diethylnitrosamine; Dose-Response Relationship, Drug; Genes, myc; Genetic Predisposition to Disease; Humans; Mice, Transgenic; Mitosis; Molecular Targeted Therapy; Neovascularization, Pathologic; Phenotype; Signal Transduction; Time Factors
information resource reference Rajasekaran D, Siddiq A, Willoughby JL, Biagi JM, Christadore LM, Yunes SA, Gredler R, Jariwala N, Robertson CL, Akiel MA, Shen XN, Subler MA, Windle JJ, Schaus SE, Fisher PB, Hansen U, Sarkar D. Small molecule inhibitors of Late SV40 Factor (LSF) abrogate hepatocellular carcinoma (HCC): Evaluation using an endogenous HCC model. Oncotarget. 2015 Sep 22; 6(28):26266-77. PMID: 26313006.
label Small molecule inhibitors of Late SV40 Factor (LSF) abrogate hepatocellular carcinoma (HCC): Evaluation using an endogenous HCC model.

Highlights
Search Criteria
  • small
  • molecule
  • inhibitors